tirzepatide and long covid Our Studies New long COVID clinical trial
Description
A recent Swiss study found that 26 percent of those with COVID in 2020 reported they were not fully recovered six to eight months after the initial infection
Wadden, PhD , can be reached at [email protected].
Understanding drug pricing
Resuming tirzepatide after a 12 week pause due to illness carries minimal medical risk and is far safer than attempting to manage both acute infection and worsening medication side effects simultaneously

HSA/FSA : If you have a Health Savings Account (HSA) or Flexible Spending Account (FSA), you might be able to use those funds to pay for tirzepatide